Avidity Biosciences, Inc. Income Statement

Income Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.38M2.32M6.79M9.33M9.22M9.56M10.90M
Gross Profit 0.38M2.32M6.79M9.33M9.22M9.56M10.90M
Operating items
Research & Development 8.44M14.54M37.60M101.18M150.40M190.97M303.59M
Selling, General & Administrative 2.44M5.11M13.46M26.20M37.73M54.19M86.24M
Operating Expenses 10.88M19.65M51.06M127.38M188.14M245.16M389.83M
Operating Income -10.50M-17.33M-44.28M-118.05M-178.91M-235.60M-378.94M
EBIT -10.50M-17.33M-44.28M-118.05M-178.91M-235.60M-378.94M
Non-operating items
Non Operating Investment Income -0.01M-0.18M-2.51M
Interest & Investment Income 0.21M0.10M4.97M23.97M56.88M
Other Non Operating Income -0.07M-0.06M-0.06M-0.59M-0.25M
Non Operating Income -0.72M-7.40M-0.08M-0.06M4.92M23.38M56.63M
Net income details
EBT -11.22M-24.72M-44.28M-117.95M-173.94M-211.63M-322.05M
Profit After Tax -11.22M-24.73M-44.35M-118.01M-174.00M-212.22M-322.30M
Income from Continuing Operations -11.22M-24.72M-44.28M-117.95M-173.94M-211.63M-322.05M
Consolidated Net Income -11.22M-24.72M-44.28M-117.95M-173.94M-211.63M-322.05M
Income towards Parent Company -11.22M-24.72M-44.28M-117.95M-173.94M-211.63M-322.05M
Net Income towards Common Stockholders -11.22M-24.72M-44.28M-117.95M-173.94M-211.63M-322.05M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 37.53M46.90M54.46M74.10M119.31M
Shares Outstanding (Diluted Average) 21.66M41.43M52.16M73.01M111.58M
EBITDA -11.22M-24.73M-44.36M-118.19M-176.51M-209.40M-319.52M
Shares Outstanding 2.99M37.57M47.75M